#065 - David Segal: Rare Diseases, Angelman Syndrome, and the Power of Gene Editing

Today we talk with David Segal, Professor of Biochemistry and Molecular Medicine at the UC Davis School of Medicine. His research focuses on genome engineering and targeted gene regulation for applications in neurological disorders, particularly Angelman Syndrome. In this episode we talk about the main mechanisms and challenges of molecular medicine – from CRISPR and zinc finger proteins to editing methods and financial barriers. Professor Segal explains the causes of Angelman Syndrome and details how the future of molecular medicine may assist in treating many types of rare diseases.

 

For more information about this episode, see our website: https://www.discoveringacademia.com/episodes/david-segal

This presentation is a service of Discovering Academia, and all information presented is for commercial and informational purposes only.  Discovering Academia provides no assurances as to the accuracy or completeness of the information presented and possesses no actual knowledge of any topic presented. Any opinions expressed in this presentation are solely attributed to each individual asserting the same and do not reflect the opinion of Discovering Academia.